JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB241539

Anti-KIR2DL3 antibody [EPR22195] - BSA and Azide free

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Recombinant Monoclonal KIR2DL3 antibody. Carrier free. Suitable for Flow Cyt and reacts with Human samples. Cited in 1 publication.

View Alternative Names

CD158b2, CD158B2, KIRCL23, NKAT2, KIR2DL3, Killer cell immunoglobulin-like receptor 2DL3, CD158 antigen-like family member B2, KIR-023GB, Killer inhibitory receptor cl 2-3, NKAT2a, NKAT2b, Natural killer-associated transcript 2, p58 natural killer cell receptor clone CL-6, p58.2 MHC class-I-specific NK receptor, NKAT-2, p58 NK receptor CL-6

1 Images
Flow Cytometry - Anti-KIR2DL3 antibody [EPR22195] - BSA and Azide free (AB241539)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-KIR2DL3 antibody [EPR22195] - BSA and Azide free (AB241539)

Flow cytometric analysis of primary human peripheral blood mononuclear cells (PBMC) labeling KIR2DL3 with ab224698 at 1/600 dilution (right panel) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (left panel). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed (ab150081) at 1/2000 dilution was used as the secondary antibody.

Human peripheral blood mononuclear cells were stained with PE-conjugated CD56 and rabbit IgG (Left) or KIR2DL3 (Right). Data shown were gated on viable cells.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab224698).

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR22195

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Alternative Products

Primary Antibodies

AB225740

Anti-KIR2DL3 antibody [EPR22192]

RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KIR2DL3 antibody [EPR22192] (AB225740)

  • 0
  • 0
Primary Antibodies

AB179817

Anti-KIR2DL3 antibody [EPR12281]

RabMAb|Recombinant

Flow Cytometry - Anti-KIR2DL3 antibody [EPR12281] (AB179817)

  • 0
  • 0
Primary Antibodies

AB241538

Anti-KIR2DL3 antibody [EPR22192] - BSA and Azide free

RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KIR2DL3 antibody [EPR22192] - BSA and Azide free (AB241538)

  • 0
  • 0

Complementary Products

Primary Antibodies

AB255857

Anti-KIR2DL1 + KIR2DL2 antibody [EPR22492-79] - BSA and Azide free

RabMAb|Recombinant

Flow Cytometry - Anti-KIR2DL1 + KIR2DL2 antibody [EPR22492-79] - BSA and Azide free (AB255857)

  • 0
  • 0
Primary Antibodies

AB233740

Anti-KIR3DL1 antibody [6D9F6]

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KIR3DL1 antibody [6D9F6] (AB233740)

  • 0
  • 0
Primary Antibodies

AB75846

Anti-TRIB3 antibody [EPR3151Y]

RabMAb|Recombinant|KO Validated

Immunoprecipitation - Anti-TRIB3 antibody [EPR3151Y] (AB75846)

  • 5
  • 1
Primary Antibodies

AB225636

Anti-HLA Class 1 ABC antibody [EPR22172]

BOND RX™ Validated|RabMAb|Recombinant|20ul selling size

Immunocytochemistry/ Immunofluorescence - Anti-HLA Class 1 ABC antibody [EPR22172] (AB225636)

  • 4
  • 1
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>" } } }
style
left-column

Product details

ab241539 is the carrier-free version of ab224698.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze
style
left-column
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Receptor on natural killer (NK) cells for HLA-C alleles (HLA-Cw1, HLA-Cw3 and HLA-Cw7). Inhibits the activity of NK cells thus preventing cell lysis.
See full target information KIR2DL3
style
left-column

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Histology and histopathology 40:733-743 PubMed39380528

2024

Mechanism of KMT2D-mediated epigenetic modification in IL-1β-induced nucleus pulposus cell degeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Hongjiang Liu,Haiquan Liu,Zuyu Meng,Wensheng Zhang
View all publications
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com